PharmaCell – cell therapy and regenerative medicine CMO

PharmaCell is a leading European-based Contract Manufacturing Organization (CMO) exclusively focused in the area of cell therapy and regenerative medicine. PharmaCell has experience in supporting Phase I through Phase III clinical trials and early commercial manufacturing in cell therapy in terms of manufacturing, Quality Control, storage, in-outgoing logistics and product release.

PharmaCell – cell therapy and regenerative medicine CMO

PharmaCell

Continue reading

CiMaas – cellular immonotherapy

CiMaas BV is a biotech company developing cellular immunotherapy for specific groups of cancer patients. CiMaas focuses on the development of two unique products: a cancer vaccine using the patient’s own immune (dendritic) cells and the production of donor natural killer cells. These methods can help to treat many oncological diseases.

CiMaas – cellular immonotherapy

CiMaas Continue reading